Blood test trial aims to track cancer without invasive biopsies
NCT ID NCT06367751
Summary
This study is testing how well a blood test, called a liquid biopsy, can be used to monitor cancer during a patient's regular care. It involves 159 adults with advanced solid tumors who are starting their first treatment. Researchers will see if the blood test results help guide treatment decisions and affect patient quality of life and survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Medical Oncology, University Hospital Basel
Basel, 4031, Switzerland
Conditions
Explore the condition pages connected to this study.